The StarMap Framework:
For MedTech Innovators
scaling beyond pilots
StarMap acts as a clinical–strategic compass when assumptions are expensive and mistakes compound.
Who the StarMap® is for:
MedTech Innovators
_________________________
Ideation to Scale:
Validate product–market fit before burning cash: Save €50k-100k in funds and valuable time.
The StarMap helps you avoid costly trial-and-error and gain early traction with clarity and speed.
Accellerators
_________________________
Keep them up to speed:
More than 80% of startups stagnating or failing even after accelerator programs.
StarMap sharpens cohort quality by surfacing misalignment and structural risk before it becomes portfolio drag.
Investors & VCs
_________________________
De-Risk your Invesments:
75% of venture-backed MedTech Startups never generate a Return on Investment.
Reduce hidden structural risk before deployment, improving decision quality and downside protection.
The uncomfortable truth:
Most MedTech teams are technically strong.
Many are well-funded. Some are even certified and compliant.
And still,
The Constellation Effect
Individual success factors are important, but “bleed” impact if they are viewed in isolation. True strategic resilience is found only in their system-wide alignment.
The StarMap Constellation identifies the critical intersections where clinical depth must meet commercial logic to prevent the structural failures that stall 75% of MedTech ventures.
Access the StarMap Methodology Guide to translate this system-wide logic into an actionable roadmab for your venture.
The StarMap Constellation Points
Specialization & Clinical Depth
Success doesn’t come from building a product for everyone. It comes from solving a defined, urgent problem for a clearly targeted patient group. Specialization builds clinical credibility and relevance.
“If you try to be everything to everyone, you risk being no one’s first choice.”
Predictability of Services
Technologies that disrupt clinical workflows without clear advantages are likely to be resisted.
Scalable solutions must improve efficiency, reduce variability, and slot into real-world hospital routines with minimal training or disruption.
Ambulantization & Digital Care models
As care shifts beyond hospitals into outpatient clinics and patients’ homes, MedTech needs to keep pace.
Tools that only work in traditional hospital settings may soon become obsolete.
Over 75% of MedTech leaders say they’re rethinking their strategies to accommodate this shift.
Cooperation & Ecosystem Fit
Interoperability and collaboration are non-negotiable. Tools that don’t integrate with existing systems (like EHRs) or fail to support cross-provider coordination often end up as siloed and unused.
“Future success will depend on targeting the entire care pathway, not just standalone products,” notes 86% of MedTech executives surveyed.
Economic Viability
Even a clinically brilliant tool will stall if hospitals can’t justify the cost. ROI, reimbursement pathways, and a compelling business case are all essential.
It’s not just about clinical benefit; it’s about financial sustainability for all stakeholders.
Quality of Care & Patient Safety
Evidence of improved outcomes is fast becoming the gold standard.
Whether it’s fewer readmissions, faster recovery, or higher patient satisfaction, measurable impact is now a key driver of adoption and funding.
Implementation Friction
The best product means nothing if it never gets used. Lengthy onboarding, resistance from staff, IT challenges, or regulatory delays can derail even the most promising solution.
Minimizing this friction is critical to scaling adoption.
“It’s great to see the StarMap gaining recognition, bridging that gap between innovation and real-world impact is exactly what the MedTech field needs.”
MedTech World
Success Stories
“EvoMed Consulting didn’t just advise us on individual questions, they guide us through complexity. Dr. Havkic helped us understand where clinical reality, regulation, and reimbursement truly intersect, and how to make the right decisions at each step. That guidance gave us clarity, confidence, and a much smoother path to adoption.”
"I appriciate working with Dr. Havkic. He consistantly manages to bring together medical and business perspectives - and this is also the case with innovative tech topics like analytics."
“I was impressed with the medical expertise of the EvoMed-Team and their ability to integrate it seamlessly into our business operations. Their consulting services were invaluable in helping navigate the complex medical imaging diagnostic industry, making our products even more user-friendly and patient-safe.”
"The most eye-opening insight was realizing how crucial technical integration will be in the future, and which metrics I need to track as soon as I start working with clinics to support further sales. It also highlighted which data I should already showcase on the website and in conversations. I now have a clear view of the immediate, mid-term, and long-term steps."
Bedside-to-Boardroom
“As an ICU Lead and Strategic Advisor, I have spent my career stabilizing both critical patients and stalling MedTech ventures by bridging the gap between clinical reality and commercial logic.
The StarMap is not a theoretical framework, it is the codified methodology I use to isolate the structural risks that cause 75% of innovations to fail.”
– Dr. med. univ. Amel Havkic, MBA
Review our Clinical Case Reports to see the documented evidence of how we translate this alignment into investment-ready market traction.
How well are your stars aligned?
Answer 14 questions to find how well your solution is aligned with the StarMap constellation points.